Calciphylaxis Following Parathyroidectomy in Chronic Kidney Disease Patients-Case Report and Literature Review.

IF 3.9 3区 工程技术 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Nada Akad, Stefana Catalina Bilha, Mugurel Apetrii, Fawzy Akad, Madalina Bilha, Mihai Hogas, Simona Hogas, Maria-Christina Ungureanu, Cristina Preda, Adrian Covic
{"title":"Calciphylaxis Following Parathyroidectomy in Chronic Kidney Disease Patients-Case Report and Literature Review.","authors":"Nada Akad, Stefana Catalina Bilha, Mugurel Apetrii, Fawzy Akad, Madalina Bilha, Mihai Hogas, Simona Hogas, Maria-Christina Ungureanu, Cristina Preda, Adrian Covic","doi":"10.3390/biomedicines13030715","DOIUrl":null,"url":null,"abstract":"<p><p>Calcific uremic arteriolopathy, also known as calciphylaxis, is a rare and often fatal condition most commonly occurring in patients with end-stage renal disease (ESRD). It is marked by extensive vascular calcification, resulting in tissue ischemia and the development of distinctive skin lesions. We report the case of a 38-year-old male with ESRD due to polycystic kidney disease, who developed calciphylaxis lesions following total parathyroidectomy (PTx). We also performed an electronic search of PubMed and Google Scholar from inception until December 2024, using the following keywords: 'chronic kidney disease', 'dialysis', 'calciphylaxis', 'calcific uremic arteriolopathy', 'secondary hyperparathyroidism', and 'parathyroidectomy'. A literature review of calciphylaxis cases following PTx in chronic kidney disease (CKD) patients identified 14 cases reported up to the manuscript's writing. Although PTx can be a treatment option for calciphylaxis related to severe secondary hyperparathyroidism (SHPT), leading to clinical improvement in some patients, there are atypical calciphylaxis cases occurring after PTx. While the mechanism is not fully understood, the sudden reduction in parathormone (PTH) levels leading to hypocalcemia and decreased bone turnover, together with an increased calcium loading in a patient at risk for abnormal mineralization, may promote vascular and soft tissue calcification. However, the long-term impact of severe SHPT with a delayed post-PTx manifestation cannot be ruled out. Clinicians should consider calciphylaxis in CKD patients with new painful skin lesions. Skin biopsy remains controversial, but a thorough clinical examination, and, in some cases, imaging are essential for a correct diagnosis. A multidisciplinary, personalized approach is crucial, with careful management of post-PTx hypocalcemia and calcium supplementation. Further research is needed to enhance understanding and treatment strategies.</p>","PeriodicalId":8937,"journal":{"name":"Biomedicines","volume":"13 3","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11940037/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedicines","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/biomedicines13030715","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Calcific uremic arteriolopathy, also known as calciphylaxis, is a rare and often fatal condition most commonly occurring in patients with end-stage renal disease (ESRD). It is marked by extensive vascular calcification, resulting in tissue ischemia and the development of distinctive skin lesions. We report the case of a 38-year-old male with ESRD due to polycystic kidney disease, who developed calciphylaxis lesions following total parathyroidectomy (PTx). We also performed an electronic search of PubMed and Google Scholar from inception until December 2024, using the following keywords: 'chronic kidney disease', 'dialysis', 'calciphylaxis', 'calcific uremic arteriolopathy', 'secondary hyperparathyroidism', and 'parathyroidectomy'. A literature review of calciphylaxis cases following PTx in chronic kidney disease (CKD) patients identified 14 cases reported up to the manuscript's writing. Although PTx can be a treatment option for calciphylaxis related to severe secondary hyperparathyroidism (SHPT), leading to clinical improvement in some patients, there are atypical calciphylaxis cases occurring after PTx. While the mechanism is not fully understood, the sudden reduction in parathormone (PTH) levels leading to hypocalcemia and decreased bone turnover, together with an increased calcium loading in a patient at risk for abnormal mineralization, may promote vascular and soft tissue calcification. However, the long-term impact of severe SHPT with a delayed post-PTx manifestation cannot be ruled out. Clinicians should consider calciphylaxis in CKD patients with new painful skin lesions. Skin biopsy remains controversial, but a thorough clinical examination, and, in some cases, imaging are essential for a correct diagnosis. A multidisciplinary, personalized approach is crucial, with careful management of post-PTx hypocalcemia and calcium supplementation. Further research is needed to enhance understanding and treatment strategies.

钙化性尿毒症动脉病变又称钙血症,是一种罕见的致命疾病,最常见于终末期肾病(ESRD)患者。该病的特点是血管广泛钙化,导致组织缺血和出现独特的皮肤病变。我们报告了一例因多囊肾导致 ESRD 的 38 岁男性患者,他在接受甲状旁腺全切除术(PTx)后出现了钙化性病变。我们还使用以下关键词对 PubMed 和 Google Scholar 进行了电子检索,检索时间从开始到 2024 年 12 月:慢性肾病"、"透析"、"钙化性尿毒症动脉病变"、"继发性甲状旁腺功能亢进 "和 "甲状旁腺切除术"。对慢性肾脏病(CKD)患者进行PTx治疗后发生钙化性紫癜的文献回顾发现,截至手稿撰写前,共报告了14例钙化性紫癜病例。虽然PTx是治疗与严重继发性甲状旁腺功能亢进症(SHPT)相关的钙虹吸症的一种方法,可使一些患者的临床症状得到改善,但PTx术后也会出现一些非典型的钙虹吸症病例。虽然其机制尚不完全清楚,但副甲状腺激素(PTH)水平的突然降低导致低钙血症和骨转换减少,再加上有矿化异常风险的患者钙负荷增加,可能会促进血管和软组织钙化。但是,也不能排除严重的 SHPT 在治疗后延迟表现的长期影响。对于出现新的疼痛性皮损的慢性肾脏病患者,临床医生应考虑钙化病。皮肤活检仍存在争议,但全面的临床检查以及某些情况下的影像学检查对于正确诊断至关重要。采用多学科、个性化的方法至关重要,同时要谨慎处理 PTx 后低钙血症并补充钙剂。需要进一步开展研究,以加深对这一疾病的了解并改进治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biomedicines
Biomedicines Biochemistry, Genetics and Molecular Biology-General Biochemistry,Genetics and Molecular Biology
CiteScore
5.20
自引率
8.50%
发文量
2823
审稿时长
8 weeks
期刊介绍: Biomedicines (ISSN 2227-9059; CODEN: BIOMID) is an international, scientific, open access journal on biomedicines published quarterly online by MDPI.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信